tiprankstipranks
Trending News
More News >
MCI Onehealth Technologies, Inc. Class A (TSE:AIDX)
TSX:AIDX
Canadian Market

MCI Onehealth Technologies, Inc. Class A (AIDX) Earnings Dates, Call Summary & Reports

Compare
111 Followers

Earnings Data

Report Date
Aug 18, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.02
Last Year’s EPS
0.02
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -4.64%
|
Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Neutral
Healwell AI's earnings call reflects a strong growth trajectory fueled by strategic acquisitions and expansion in AI and data science segments. Despite facing challenges such as increased net loss and adjusted EBITDA loss, the company has made significant progress in revenue growth and strategic partnerships. The impact of external factors like the Inflation Reduction Act poses challenges, but the company remains optimistic about future growth and profitability.
Company Guidance
During the Q3 2024 earnings call for Healwell AI, the company provided a comprehensive overview of its financial and strategic progress. Key financial metrics included a significant increase in quarterly revenue to CAD 13.7 million from CAD 1.6 million the previous year, primarily driven by strategic acquisitions. Adjusted gross profit rose to CAD 5.9 million, with a gross margin of 43%, up from 20% in Q3 2023. However, the company reported an adjusted EBITDA loss of CAD 3.4 million and a net loss of CAD 11.1 million. The call highlighted the company's impressive growth trajectory, with annualized revenue run rate increasing eightfold to CAD 58.4 million. Strategic acquisitions, such as VeroSource Solutions and BioPharma Services, were noted as transformational, enhancing Healwell's financial profile and capabilities. The company anticipates reaching a CAD 100 million revenue run rate and profitability on an adjusted EBITDA basis in the near future. Healwell also emphasized its expansion in AI solutions and clinical research, with 27 signed master service agreements with life sciences partners, including seven of the top ten largest pharmaceutical companies.
Significant Revenue Growth
Healwell achieved quarterly revenues of $13.7 million in Q3 2024, compared to $1.6 million in the same quarter last year, driven by recent acquisitions.
AI and Data Science Segment Expansion
The AI and data science segment experienced an impressive 2,800% revenue growth this quarter as compared to the same quarter of 2023.
Increase in Master Service Agreements
Healwell's AI and data science subsidiaries executed 5 new MSAs in Q3 2024, bringing the cumulative total to 27, including partnerships with 7 of the top 10 largest pharmaceutical companies.
Strategic Acquisitions and Expansion
Acquired VeroSource Solutions and BioPharma Services, enhancing clinical research capabilities and financial profile. Expanded clinical research services for the pharmaceutical industry.
Prix Galien USA 2024 Award
Pentavere received the prestigious Prix Galien USA 2024 Award for Best Digital Health start-up in AI for life sciences.

MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:AIDX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2025
2025 (Q2)
-0.02 / -
0.02
May 13, 2025
2025 (Q1)
-0.04 / -0.08
-0.06-33.33% (-0.02)
Mar 26, 2025
2024 (Q4)
-0.03 / -0.23
-0.1-130.00% (-0.13)
Nov 12, 2024
2024 (Q3)
-0.04 / -0.06
-0.1457.14% (+0.08)
Aug 12, 2024
2024 (Q2)
-0.03 / 0.02
-0.18111.11% (+0.20)
May 14, 2024
2024 (Q1)
-0.03 / -0.06
-0.1560.00% (+0.09)
Mar 29, 2024
2023 (Q4)
-0.10 / -0.10
-0.07-42.86% (-0.03)
Nov 15, 2023
2023 (Q3)
- / -0.14
-0.1822.22% (+0.04)
Aug 15, 2023
2023 (Q2)
- / -0.18
-0.08-125.00% (-0.10)
May 16, 2023
2023 (Q1)
- / -
-0.09
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:AIDX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
C$1.51C$1.63+7.95%
Mar 26, 2025
C$1.60C$1.63+1.87%
Nov 12, 2024
C$1.77C$1.81+2.26%
Aug 12, 2024
C$2.06C$2.00-2.91%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) report earnings?
MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
    What is MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) earnings time?
    MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) earnings time is at Aug 18, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:AIDX EPS forecast?
          TSE:AIDX EPS forecast for the fiscal quarter 2025 (Q2) is -0.02.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis